‘A systematic failure': She was killed outside a Tacoma shop as a clerk's mental health spiraled
Odessa Easterlin, 37, was fatally stabbed outside Candy Market, located at 767 Market St., on April 30, 2022. The suspect, 55-year-old Abdelhakim Choubabi, was charged with first-degree murder but the case was later dismissed after a judge found him mentally incompetent to stand trial.
The lawsuit, filed March 6 in Pierce County Superior Court, laid out a series of alleged failures that it said led to Easterlin's murder as it accused Tacoma police, mental health provider Telecare Corporation, a Telecare employee and Candy Market of negligence.
'Ms. Easterlin's death could absolutely have been prevented,' attorney Brett Beetham, who's representing Easterlin's estate, said in an interview Monday.
Telecare, which had treated Choubabi shortly before Easterlin's death, extended sympathies to Easterlin's family and loved ones but said it could not comment on an ongoing legal matter.
'However, we can reiterate our mission to deliver excellent and effective behavioral health services that engage individuals with complex needs in recovering their health, hopes, and dreams,' Telecare spokesperson Daphne Phillips said. 'Our staff and teams remain focused on respectfully serving our clients — people who suffer from complex and challenging mental health issues — in the Tacoma community.'
The city of Tacoma declined to comment on the lawsuit, citing its practice of not publicly addressing pending litigation. Messages left for Candy Market, using contact information available in public records, were not returned.
Choubabi was accused of stabbing Easterlin in the stomach with a large Samurai-type sword as she sat outside on the ground. He had claimed that Easterlin shoplifted and then hit him in the back of the head after he followed her outside, prompting him to return inside the store for the sword, charging documents show.
Beetham said store footage from the day of the killing refuted Choubabi's statements, revealing that Easterlin didn't shoplift and had no sort of interaction with the clerk.
Choubabi was diagnosed with paranoid schizophrenia as early as 2004 and had been treated several times over the years for the illness, including after allegedly stabbing his pregnant wife and two others in 2003, according to the lawsuit.
He began working at Candy Market around 2017, the suit said. It claimed that store ownership was aware of Choubabi's mental health problems and should not have allowed him to work unsupervised nor kept a sword behind the cashier's counter.
At the time of Easterlin's killing, Choubabi's mental health was in rapid decline, culminating in three roughly week-long commitments at three mental health clinics in April 2022 to treat auditory and visual hallucinations, the suit said. He reported hearing commands from Satan to hurt people, according to the suit.
Ten days before Easterlin was killed, and after Choubabi was reportedly discharged from a second clinic despite persisting psychiatric problems, Choubabi called 911 from work to report that he was going to hurt himself or someone else, according to the lawsuit. He walked up South 9th Street with a knife in his hand and Tacoma police took him to a local hospital where he was transferred to Telecare North Sound E&T in Sedro-Woolley, the suit said.
Telecare North Sound E&T discharged Choubabi after six days, although he complained of hearing voices and his medication not working, the suit said. The clinic referred him to his primary care provider for an appointment scheduled for the following week, according to the suit.
Easterlin would be dead in three days.
Back again at work, Choubabi called 911 once more — this time just three hours before the fatal stabbing. He requested Easterlin, who was apparently homeless and also suffering from mental health problems, be moved from the front of the store. A responding officer watched Easterlin walking away, documented observing mental health issues and cleared the call without getting out of his patrol vehicle, according to the suit and Beetham.
'Tacoma PD needs to do a lot better than just a drive-by,' Beetham said.
The officer should have investigated, consistent with department policies that prescribe intervening in such situations, since Easterlin had been exhibiting signs of mental distress, including talking to herself, not wearing pants and urinating in public, according to the suit.
If the policy had been followed, the suit said, Easterlin could have been removed from the scene and it would have been discovered that Choubabi was detained with a dangerous weapon only 10 days earlier.
The lawsuit is seeking unspecified damages and legal fees. More than anything, Beetham said Easterlin's family wants justice and protection for others in Easterlin's situation.
'It's just a systematic failure,' he said, singling out Tacoma police and Telecare. 'We want to hold them accountable to make sure … this does not happen to anyone else, especially our community's most vulnerable.'

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
5 hours ago
- Yahoo
Teladoc Health expands in Australia with Telecare acquisition
Teladoc Health has announced the acquisition of Telecare, which provides virtual allied and specialist healthcare services in Australia. This strategic move aims to expand Teladoc Health's footprint in the Australian healthcare market, providing broader access to virtual care for individuals in the country. Telecare operates a virtual care clinic and has a network of more than 300 specialists across over 30 specialities. The company has played a significant role in reducing wait times for patients and enhancing speciality care access, particularly in underserved areas. Its services cater to appointments referred by general practitioners (GPs) and public hospitals. The acquisition aligns with the enterprise strategy of Teladoc Health to grow its international business. The company has been operating in Australia for 15 years and offers virtual health services through partnerships with hospitals and insurers. Recently, Teladoc Health introduced virtual care solutions to the hospital sector in Australia, including virtual neonatology at Mater Misericordiae University Hospital. Teladoc Health International president Carlos Nueno said: 'Teladoc Health is improving access to care globally through virtual innovation and technology. 'We believe joining forces with Telecare will help us advance our mission—especially for those in regional and remote areas—by combining our technological solutions and services to support one of the leading health markets around the world.' In 2024, Teladoc Health reported revenues exceeding $2.5bn and facilitates access to care for over 100 million individuals. It has integrated its technology across many health systems and hospitals globally. This includes Charité in Germany and the NHS in the UK. Following the acquisition, Telecare will continue to operate under its brand, led by the management team and existing founders, ensuring continuity and local expertise for the Australian market. Financial terms of the transaction have not been disclosed. "Teladoc Health expands in Australia with Telecare acquisition" was originally created and published by Hospital Management, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
5 hours ago
- Yahoo
Teladoc acquires Australian virtual care firm Telecare
This story was originally published on Healthcare Dive. To receive daily news and insights, subscribe to our free daily Healthcare Dive newsletter. Dive Brief: Teladoc Health has acquired Australian virtual care provider Telecare as the telehealth company looks to bolster its international presence. Financial terms of the deal weren't disclosed, and the transaction is expected to be immaterial to Teladoc's financial results in 2025, the company said in a press release Thursday. The purchase comes on the heels of two other acquisitions by Teladoc this year. The telehealth company bought virtual preventive care firm Catapult Health in February and mental healthcare provider UpLift in April. Dive Insight: Telecare operates a virtual care clinic with more than 30 specialties, handling appointments referred by general practitioners and offering services to public hospitals in Australia, according to a press release. The company will continue to operate in the country under its existing brand with its current management team. The deal closed on Aug. 8, Teladoc said. 'We believe joining forces with Telecare will help us advance our mission—especially for those in regional and remote areas—by combining our technological solutions and services to support one of the leading health markets around the world,' Carlos Nueno, Teladoc's president of international, said in a statement. The purchase of Telecare comes as Teladoc has prioritized international expansion. In the second quarter, the firm's international revenue increased 10% to $112.2 million. The firm's international business now accounts for more than 15% of Teladoc's consolidated revenue, CEO Chuck Divita said on a second quarter earnings call last month. Teladoc already operates a 'robust' international business in its integrated care segment, which includes business-to-business virtual care offerings, he said. The company has operated in Australia for 15 years, offering virtual care services through insurers and hospitals. Teladoc has also recently deployed other products in the country, including a virtual neonatology offering at the Mater Misericordiae University Hospital, and a virtual telesurgery support system with Central Queensland Hospital and Health Service, the company said in the Thursday press release. 'We continue to evaluate opportunities to increase our position across both existing and new geographies,' Divita said on the earning call in July. M&A should also play an important role for Teladoc, the CEO said at a conference this summer. Buying Catapult, which offers a virtual annual exam with an in-home diagnostic kit, should allow Teladoc to catch members' health conditions early and funnel them toward its other offerings, like chronic condition management programs, the company said. And the UpLift purchase aims to speed the company's ability to accept insurance coverage for care delivered by its direct-to-consumer mental health segment, BetterHelp, executives said. Recommended Reading Teladoc beats Wall Street expectations in Q2 amid strategic revamp


CNBC
7 hours ago
- CNBC
Novo Nordisk offers diabetes drug Ozempic for less than half the price for cash-paying U.S. patients
Novo Nordisk on Monday said it now offers cash-paying U.S. patients its blockbuster diabetes treatment Ozempic for less than half its monthly list price, as drugmakers face mounting political pressure to lower prices in the country. Patients can pay $499 in cash per month for three dose sizes of Ozempic. They can get the price through platforms including the drug's official website, Novo Nordisk's patient assistance program and the company's recently launched direct-to-consumer online pharmacy, the latter of which also ships the injection directly to patients' homes. Drug savings company GoodRx will also offer Ozempic and its weight loss counterpart Wegovy for $499 per month, making the discounts available at more than 70,000 pharmacies nationwide, according to a Novo Nordisk release. Novo Nordisk's cash-pay offering will expand access to eligible Type 2 diabetes patients who don't have insurance coverage for the weekly injection. In March, the company began to offer Wegovy for half its list price to cash-paying Americans. Ozempic's list price before insurance and other rebates is almost $1,350 per month, and has been a frequent target of political and public blowback in recent years. The new offer comes after President Donald Trump in July sent separate letters to Novo Nordisk and 16 other drugmakers, calling on them to take steps to lower medication prices in the U.S. Among other suggested actions, he urged them to adopt models that sell medicines directly to consumers or businesses. The efforts aim to make Ozempic and Wegovy available to more people, while also ensuring that patients use the branded medication instead of cheaper compounded copycats. Those drugs exploded in popularity during a now-resolved U.S. shortage of Novo Nordisk's semaglutide, the active ingredient in both drugs. While Ozempic "is well covered in the US, let's not forget that there are some patients who pay out-of-pocket for this vital medicine," Dave Moore, executive vice president of U.S. operations and global business development at Novo Nordisk, said in the release. "We believe that if even a single patient feels the need to turn to potentially unsafe and unapproved knockoff alternatives, that's one too many." Eli Lilly has similarly moved to slash the price of its popular obesity and diabetes drugs for cash-paying patients. The two companies are fighting to dominate the market for so-called GLP-1s, which mimic certain gut hormones to suppress appetite and regulate blood sugar.